107 related articles for article (PubMed ID: 10380822)
1. Conjugate chemistry and cellular processing of EGF-dextran.
Carlsson J; Blomquist E; Gedda L; Liljegren A; Malmström PU; Sjöström A; Sundin A; Westlin JE; Zhao Q; Tolmachev V; Lundqvist H
Acta Oncol; 1999; 38(3):313-21. PubMed ID: 10380822
[TBL] [Abstract][Full Text] [Related]
2. Conjugate chemistry, iodination and cellular binding of mEGF-dextran-tyrosine: preclinical tests in preparation for clinical trials.
Zhao Q; Blomquist E; Bolander H; Gedda L; Hartvig P; Janson J; Lundqvist H; Mellstedt H; Nilsson S; Nistèr M; Sundin A; Tolmachev V; Westlin J; Carlsson J
Int J Mol Med; 1998 Apr; 1(4):693-702. PubMed ID: 9852284
[TBL] [Abstract][Full Text] [Related]
3. Preparation and purification of an end to end coupled mEGF-dextran conjugate.
Zhao Q; Gottschalk I; Carlsson J; Arvidsson LE; Oscarsson S; Medin A; Ersson B; Janson JC
Bioconjug Chem; 1997; 8(6):927-34. PubMed ID: 9404668
[TBL] [Abstract][Full Text] [Related]
4. Binding of epidermal growth factor-dextran conjugates to cultured glioma cells.
Andersson A; Holmberg A; Carlsson J; Carlsson J; Pontén J; Westermark B
Int J Cancer; 1991 Feb; 47(3):439-44. PubMed ID: 1704355
[TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of an end-end coupled mEGF-dextran conjugate using a cultured human glioma cell line.
Zhao Q; Carlsson J
Int J Oncol; 1997 Dec; 11(6):1263-9. PubMed ID: 21528333
[TBL] [Abstract][Full Text] [Related]
6. Internalization and excretion of epidermal growth factor-dextran-associated radioactivity in cultured human squamous-carcinoma cells.
Olsson P; Lindström A; Carlsson J
Int J Cancer; 1994 Feb; 56(4):529-37. PubMed ID: 7509322
[TBL] [Abstract][Full Text] [Related]
7. Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor.
Carlsson J; Gedda L; Grönvik C; Hartman T; Lindström A; Lindström P; Lundqvist H; Lövqvist A; Malmqvist J; Olsson P
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):105-15. PubMed ID: 7521866
[TBL] [Abstract][Full Text] [Related]
8. Binding, internalization and excretion of TGF alpha-dextran associated radioactivity in cultured human glioma cells.
Lövqvist A; Lindström A; Carlsson J
Cancer Biother; 1993; 8(4):345-56. PubMed ID: 7528599
[TBL] [Abstract][Full Text] [Related]
9. Penetration and binding of epidermal growth factor-dextran conjugates in spheroids of human glioma origin.
Lindström A; Carlsson J
Cancer Biother; 1993; 8(2):145-58. PubMed ID: 7528598
[TBL] [Abstract][Full Text] [Related]
10. Binding, internalization and degradation of EGF-dextran conjugates in two human bladder-cancer cell lines.
Sjöström A; Bue P; Malmström PU; Nilsson S; Carlsson J
Int J Cancer; 1997 Feb; 70(4):383-9. PubMed ID: 9033643
[TBL] [Abstract][Full Text] [Related]
11. Direct identification of residues of the epidermal growth factor receptor in close proximity to the amino terminus of bound epidermal growth factor.
Woltjer RL; Lukas TJ; Staros JV
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7801-5. PubMed ID: 1380167
[TBL] [Abstract][Full Text] [Related]
12. Cellular retention of radioactivity and increased radiation dose. Model experiments with EGF-dextran.
Sundberg AL; Blomquist E; Carlsson J; Steffen AC; Gedda L
Nucl Med Biol; 2003 Apr; 30(3):303-15. PubMed ID: 12745022
[TBL] [Abstract][Full Text] [Related]
13. Processing and transfer of epidermal growth factor in developing rat jejunum and ileum.
Rao RK; Koldovský O; Korc M; Pollack PF; Wright S; Davis TP
Peptides; 1990; 11(6):1093-102. PubMed ID: 2087434
[TBL] [Abstract][Full Text] [Related]
14. Effects of dextranation on the pharmacokinetics of short peptides. A PET study on mEGF.
Zhao Q; Tolmachev V; Carlsson J; Lundqvist H; Sundin J; Janson JC; Sundin A
Bioconjug Chem; 1999; 10(6):938-46. PubMed ID: 10563762
[TBL] [Abstract][Full Text] [Related]
15. Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapy.
Gedda L; Olsson P; Pontén J; Carlsson J
Bioconjug Chem; 1996; 7(5):584-91. PubMed ID: 8889021
[TBL] [Abstract][Full Text] [Related]
16. Effects of EGF-dextran-tyrosine-131I conjugates on the clonogenic survival of cultured glioma cells.
Andersson A; Capala J; Carlsson J
J Neurooncol; 1992 Nov; 14(3):213-23. PubMed ID: 1281225
[TBL] [Abstract][Full Text] [Related]
17. Binding of 125I after administration of 125I-EGF-dextran, 125I-EGF or 125I to human bladder cancer spheroids.
Sjöström A; Bue P; Malmstrom P; Carlsson J
Int J Oncol; 2000 Sep; 17(3):559-64. PubMed ID: 10938398
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of a bifunctionally spin-labeled mutant of murine epidermal growth factor for saturation-transfer electron paramagnetic resonance studies of the growth factor/receptor complex.
Rousseau DL; Guyer CA; Beth AH; Papayannopoulos IA; Wang B; Wu R; Mroczkowski B; Staros JV
Biochemistry; 1993 Aug; 32(31):7893-903. PubMed ID: 8394119
[TBL] [Abstract][Full Text] [Related]
19. Development of a human epidermal growth factor derivative with EGFR-blocking and depleted biological activities: A comparative in vitro study using EGFR-positive breast cancer cells.
Mehrabi M; Mansouri K; Soleymani B; Hoseinkhani Z; Shahlaie M; Khodarahmi R
Int J Biol Macromol; 2017 Oct; 103():275-285. PubMed ID: 28501600
[TBL] [Abstract][Full Text] [Related]
20. High-yield covalent attachment of epidermal growth factor to its receptor by kinetically controlled, stepwise affinity cross-linking.
Woltjer RL; Weclas-Henderson L; Papayannopoulos IA; Staros JV
Biochemistry; 1992 Aug; 31(32):7341-6. PubMed ID: 1324711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
